As pharma organizations invest heavily in digital tools, network redesign, and advanced analytics, many still struggle to translate transformation strategies into consistent, day-to-day execution. This panel focuses on how operational leaders are closing the gap between ambition and reality—ensuring new processes, technologies, and governance models actually work at the plant, warehouse, and distribution levels. Senior supply chain and operations leaders will share how they are driving adoption, managing change, aligning KPIs, and embedding continuous improvement across manufacturing, logistics, and quality teams—without slowing execution or overwhelming the organization.

Key Takeaways

• Convert transformation roadmaps into executable operating plans with clear ownership and metrics
• Drive adoption on the front lines through change management, capability building, and realistic timelines
• Balance standardization and flexibility across sites, regions, and partners to improve performance at scale

As biologics, cell & gene therapies, radiopharmaceuticals, and other temperature-sensitive modalities scale, cold chain has become one of the most critical (and fragile) components of pharma logistics. This panel brings together leading manufacturers and logistics partners to discuss how they’re designing more resilient systems, strengthening monitoring and control, and adapting to new therapy requirements across the global network. Speakers will share strategies for ensuring product integrity, expanding cryogenic capability, enabling faster decision-making, and preparing the cold chain for the next decade of innovation.

• Strengthen end-to-end visibility and exception management to prevent temperature excursions and protect high-value assets
• Adapt cold chain designs to accommodate emerging modalities, from CAR-T to radiopharma to personalized therapies
• Increase agility through smarter packaging, lane strategy optimization, and tighter collaboration with partners